RECRUITING

The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching goal of this research is to use machine learning analysis of high-resolution data-collected by wearable technology-of cardiothoracic surgical patients to assess recovery and detect complications at their earliest stage

Official Title

The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications

Quick Facts

Study Start:2021-07-10
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04824066

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 years or older undergoing cardiothoracic surgery that is male or a non-pregnant female and are amenable to using one of the wearable devices of interest (Fitbit, iWatch, Biostrap).
  2. 2. Individuals willing to provide informed consent and who have capacity for all study procedures
  1. 1. Individuals with mental incapacity and/or cognitive impairment that would preclude adequate understanding of, or cooperation with the study protocol.
  2. 2. Any pregnant participant.
  3. 3. Severe irreversible pulmonary hypertension.
  4. 4. Congenital heart disease
  5. 5. Chronic renal insufficiency or undergoing chronic renal replacement therapy
  6. 6. Liver cirrhosis

Contacts and Locations

Study Contact

Chi-Fu Jeffrey Yang, MD
CONTACT
617-726-5200
cjyang@mgh.harvard.edu
Isha Mehta Warikoo, MD
CONTACT
857-250-1355
imehtawarikoo@mgh.harvard.edu

Principal Investigator

Chi-Fu Jeffrey Yang
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Chi-Fu Jeffrey Yang, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-10
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2021-07-10
Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Surgery--Complications